BOSTON - Compass Therapeutics, Inc. (NASDAQ:CMPX) announced Tuesday it will present preclinical data on its cancer drug candidate CTX-10726 at the Society for Immunotherapy of Cancer Annual Meeting ...

SOUTH SAN FRANCISCO - Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) announced Monday that final data from its Phase 1/1b trial of soquelitinib in patients with T cell lymphoma will be presented at the ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation to report results from real ...

New data from Phase 1/2 study of enzomenib (DSP-5336) in patients with relapsed/refractory acute myeloid leukemia (AML) show promising clinical activity across a wide range of potentially therapeutic ...

MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...

CAMBRIDGE, Mass., Nov. 3, 2025 /PRNewswire/ -- CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that ...